Drug-drug Interaction Study of Evobrutinib With Midazolam in Healthy Participants
Clinical trial NCT04697511 · COMPLETED
Trial details
- NCT number
- NCT04697511
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2021-02-25
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.